ArticleOncoimmunology2021

NFATc3 inhibits hepatocarcinogenesis and HBV replication via positively regulating RIG-I-mediated interferon transcription.

Xiaobin Zao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.